DENALI THERAPEUTICS INC (DNLI)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Ryan J. Watts, Ph.D. President and Chief Executive Officer | 2025 | $718,000 | $676,706 | $1,151,867 | $2,180,003 | $0 | $24,939 | $4,751,515 |
| 2024 | $690,100 | $627,969 | $1,819,942 | $3,405,851 | $0 | $13,800 | $6,557,662 | |
| 2023 | $670,000 | $462,289 | $2,272,291 | $4,461,487 | $0 | $13,200 | $7,879,267 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Alexander O. Schuth, M.D. Chief Operating and Financial Officer and Secretary | 2025 | $552,000 | $360,175 | $1,151,867 | $2,180,003 | $0 | $14,000 | $4,258,045 |
| 2024 | $535,600 | $337,416 | $1,092,128 | $2,043,815 | $0 | $13,800 | $4,022,759 | |
| 2023 | $520,000 | $269,093 | $1,136,146 | $2,230,744 | $0 | $13,200 | $4,169,183 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Carole Ho, M.D. Chief Medical Officer and Head of Development until November 14, 2025 | 2025 | $483,000 | $0 | $1,151,867 | $2,180,003 | $0 | $14,000 | $3,828,870 |
| 2024 | $535,600 | $337,416 | $1,092,128 | $2,043,815 | $0 | $13,800 | $4,022,759 | |
| 2023 | $520,000 | $269,093 | $1,136,146 | $2,230,744 | $0 | $13,200 | $4,169,183 |